|
ABCA7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66888725061654E-12 |
| Normal-vs-Stage2 |
4.41319999999745E-05 |
| Normal-vs-Stage3 |
2.14909999999291E-05 |
| Normal-vs-Stage4 |
1.443600E-01 |
| Stage1-vs-Stage2 |
7.221900E-02 |
| Stage1-vs-Stage3 |
1.244600E-01 |
| Stage1-vs-Stage4 |
1.066640E-01 |
| Stage2-vs-Stage3 |
8.485200E-01 |
| Stage2-vs-Stage4 |
2.218800E-01 |
| Stage3-vs-Stage4 |
2.017600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62525548574877E-12 |
| Normal-vs-AfricanAmerican |
6.6812999577337E-09 |
| Normal-vs-Asian |
4.451800E-02 |
| Caucasian-vs-AfricanAmerican |
5.923000E-01 |
| Caucasian-vs-Asian |
9.638800E-01 |
| AfricanAmerican-vs-Asian |
7.862400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
5.4537999671922E-09 |
| Male-vs-Female |
3.479200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.158900E-04 |
| Normal-vs-Extreme_Weight |
5.87307980026708E-13 |
| Normal-vs-Obese |
7.02290003928852E-10 |
| Normal-vs-Extreme_Obese |
1.537870E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.505800E-01 |
| Normal_Weight-vs-Obese |
8.019400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.323000E-01 |
| Extreme_Weight-vs-Obese |
3.447000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.493200E-01 |
| Obese-vs-Extreme_Obese |
6.071400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.421100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.15483186849497E-12 |
| Normal-vs-Age(61-80Yrs) |
1.68198788230711E-12 |
| Normal-vs-Age(81-100Yrs) |
5.860200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.437600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.773400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.953800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.776400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.638600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.161520E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.968400E-04 |
| Normal-VS-KIRP CIMP |
1.183870E-03 |
| Normal-VS-Unclassified PRCC |
5.62630000366937E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.69069000000022E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.708200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.007800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.110640E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.215100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.565400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.82779999999572E-06 |
| Normal-vs-N1 |
5.781400E-04 |
| Normal-vs-N2 |
3.914400E-01 |
| N0-vs-N1 |
6.978000E-01 |
| N0-vs-N2 |
7.028000E-01 |
| N1-vs-N2 |
8.050800E-01 |
|
|
